41

Visgeneer

4197 · TWO · Healthcare / Biotechnology

7.77TWD-0.03 (-0.38%)

Price History

Full chart

Market Stats

Previous Close7.80
Open7.41
Day Range7.41 – 7.78
52-Week Range7.77 – 22.50
Volume26.20K
Market Cap271.63M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.13
Dividend Yield0.00%
Beta0.14
50-Day Avg8.88
200-Day Avg9.56

About

Visgeneer Inc. engages in the provision of health solutions in the fields of medical device, cosmetics and skin care, Zeaxanthin, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; face cream, night cream, day cream, wrinkle cream, repairing cream, whitening cream, exfoliating cream, toner, and lotions; functional essences; body lotion and spa clay mask; physical blocker, chemical blocker, and comprehensive sun protection; face wash, wash cream, cleaning cleansing mousse, cleaning cleansing gel, shampoo, and body wash; hand cream, knee cream, foot mask, hand mask, and glucosamine cream; anti-acne cream, female private cleaning lotion, skin care, skin capsules, and hair capsules; and customized skin care products. In addition, the company offers eBmonitor Blood Monitoring System, CoreSence Skincare, BOWIL Skincare, angera, ZeaSight EU Patent Zeaxanthin, and Cancer Gene Diagnostics. Visgeneer Inc. was founded in 2005 and is based in Hsinchu City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOKengshuo Dai
  • Employees0
  • HeadquartersNo. 335, Zhonghua Road, Hsinchu City, Taiwan, 30094, Taiwan
  • Websitehttps://www.visgeneer.com.tw

Leadership

  • Kengshuo DaiChairman of the Board & GM
  • Jiazhen ZhangAccounting Manager

Financials

Income Statement

Currency: TWD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue158.62M222.29M200.14M202.87M206.90M163.01M157.61M142.54M151.99M175.96M165.29M157.96M147.99M115.76M179.06M
Growth (%)-+40.14%-9.97%+1.36%+1.99%-21.22%-3.31%-9.56%+6.63%+15.77%-6.07%-4.43%-6.31%-21.78%+54.68%
Cost of Revenue121.74M137.53M107.63M127.66M124.28M94.17M118.29M104.24M114.55M113.71M98.02M90.64M80.51M62.50M110.66M
Gross Profit----82.63M68.84M39.33M38.30M37.44M62.25M67.27M67.33M67.48M53.26M68.40M
Gross Margin----39.93%42.23%24.95%26.87%24.63%35.38%40.70%42.62%45.60%46.01%38.20%
Operating Expense----63.95M66.25M63.28M71.75M67.76M61.99M63.67M52.08M63.49M73.74M73.81M
Operating Income-31.09M27.20M11.69M18.68M2.59M-23.96M-33.45M-30.32M256.00K3.60M15.25M3.99M-20.48M-5.41M
Operating Margin-13.99%13.59%5.76%9.03%1.59%-15.20%-23.47%-19.95%0.15%2.18%9.65%2.69%-17.69%-3.02%
EBITDA-------9.26M-9.01M-10.49M20.68M19.16M34.44M21.17M-804.00K20.27M
EBITDA Margin-------5.88%-6.32%-6.90%11.75%11.59%21.80%14.30%-0.69%11.32%
Net Income--32.22M20.22M22.29M381.00K-30.66M-31.89M-31.75M603.00K820.00K12.35M-19.59M-17.73M5.25M
Net Income Margin--16.10%9.97%10.77%0.23%-19.45%-22.37%-20.89%0.34%0.50%7.82%-13.24%-15.32%2.93%
R&D11.30M13.92M18.02M17.48M18.76M21.73M26.89M27.84M24.35M23.15M26.05M25.36M25.42M25.70M25.03M
R&D as % of Total Revenue7.12%6.26%9.01%8.61%9.07%13.33%17.06%19.53%16.02%13.15%15.76%16.06%17.18%22.20%13.98%
Interest Expense00000002.98M2.80M2.89M2.30M2.90M3.38M3.25M2.43M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.09%1.84%1.64%1.39%1.84%2.29%2.81%1.36%

Balance Sheet

Currency: TWD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets224.87M282.50M332.39M379.44M539.33M519.45M547.64M451.24M480.76M461.96M427.04M486.74M397.18M332.09M335.03M
Total Liabilities26.64M32.27M46.79M70.20M223.64M207.76M266.61M202.09M263.37M243.97M208.23M255.58M185.60M138.25M135.94M
Total Equity198.23M250.23M285.60M309.25M315.69M311.69M281.04M249.15M217.39M218.00M218.81M231.16M211.57M193.84M199.09M
Cash63.79M174.42M146.98M133.76M127.53M149.78M180.26M110.81M147.62M74.42M88.13M185.34M127.32M70.42M69.33M
Total Debt--------230.00M212.35M181.49M230.60M158.61M--
Net Debt------59.74M69.31M82.39M137.93M93.35M45.27M31.28M43.65M35.35M

Cash Flow

Currency: TWD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-62.20M45.42M10.45M31.86M31.54M-23.55M-2.60M-11.68M7.57M12.34M43.55M13.19M-10.22M13.37M
Investing Cash Flow-28.43M---162.31M-12.14M-5.97M-6.85M-646.00K-59.89M32.15M----
Financing Cash Flow-20.00M-27.77M124.23M2.86M60.00M-60.00M49.12M-20.87M-30.77M49.12M-72.18M--
Capital Expenditure5.48M4.35M67.29M52.20M167.80M12.49M4.82M2.78M1.48M22.10M7.89M1.69M585.00K3.80M5.38M
Free Cash Flow-------30.50M-5.42M-13.16M-14.53M4.45M41.86M12.61M-14.02M7.98M
Dividends Paid----8.21M7.14M---------
FCF to OCF------129.52%208.90%112.69%-192.00%36.07%96.11%95.57%137.22%59.73%

Key Statistics & Ratios

Market Cap271.63M
Enterprise Value332.55M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.59
Price / Book1.43
EPS-0.13
Book Value6.37
Revenue (TTM)170.72M
Gross Profit (TTM)53.14M
EBITDA2.00M
Profit Margin-2.20%
Operating Margin-8.64%
Return on Equity-1.93%
Return on Assets-1.29%
Shares Outstanding30.18M
Shares Float16.65M
Beta0.14
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20161×
0.24Jul 12, 2016
20151×
0.27Jul 9, 2015

Stock Splits

  • Jul 12, 20161050:1000
  • Jul 9, 20151050:1000
  • Jul 15, 20141100:1000